Inovio Pharmaceuticals Inc (INO)

[Ubertino]

Inovio Pharmaceuticals Receives Buy Rating from Brean Capital (INO)

Posted by Zach Kirkland on Aug 12th, 2015

Inovio Pharmaceuticals Inc logoBrean Capital reissued their buy rating on shares of Inovio Pharmaceuticals (NASDAQ:INO) in a resaerch note published onTuesday, ARN reports. The firm currently has a $20.00 price objective on the biopharmaceutical company’s stock.

Other equities research analysts also recently issued research reports about the company. Maxim Group reissued a buy rating and set a $20.00 price objective on shares of Inovio Pharmaceuticals in a report on Friday, July 24th. Zacks raised Inovio Pharmaceuticals from a hold rating to a buy rating and set a $9.00 target price for the company in a research report on Monday, May 18th. Stifel Nicolaus reissued a buy rating and issued a $19.00 price objective on shares of Inovio Pharmaceuticals in a research report on Tuesday. Finally, Piper Jaffray reaffirmed an overweight rating and issued a $31.00 target price on shares of Inovio Pharmaceuticals in a research report on Monday. One research analyst has rated the stock with a sell rating and five have assigned a buy rating to the company’s stock. The stock has a consensus rating of Buy and an average price target of $19.29.

http://www.wkrb13.com/markets/723863/inovio-pharmaceuticals-receives-buy-rating-from-brean-capital-ino/